Crispr Therapeutics' (CRSP) stock is down 37% Y/Y. Kevin Horner charts CRSP, as well as Sarepta Therapeutics (SRPT). SRPT shares hit a 52-week high last week. Tune in to find out more.
The Watch List
17 Aug 2022
SHARE
Futures
21 Jul 2023
Trading 360
18 May 2023
Morning Trade Live
18 May 2023
Futures
29 Jun 2023
Futures
30 Jun 2023
Trading 360
07 Aug 2023